Bilateral multiple serous retinal detachments following bone marrow transplantation
Purpose: To describe a case of bilateral multiple serous retinal detachments (SRD) following bone marrow transplantation (BMT), which showed bilateral response to a single unilateral intravitreal bevacizumab injection. Case Report: A 37-year-old man with acute myelogenous leukemia who had received b...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Knowledge E
2019-01-01
|
| Series: | Journal of Ophthalmic & Vision Research |
| Subjects: | |
| Online Access: | http://www.jovr.org/article.asp?issn=2008-322X;year=2019;volume=14;issue=2;spage=219;epage=222;aulast=Azadi |
| _version_ | 1811248847592095744 |
|---|---|
| author | Pejvak Azadi Alireza Lashay Mohammad Riazi Esfahani |
| author_facet | Pejvak Azadi Alireza Lashay Mohammad Riazi Esfahani |
| author_sort | Pejvak Azadi |
| collection | DOAJ |
| description | Purpose: To describe a case of bilateral multiple serous retinal detachments (SRD) following bone marrow transplantation (BMT), which showed bilateral response to a single unilateral intravitreal bevacizumab injection.
Case Report: A 37-year-old man with acute myelogenous leukemia who had received bone marrow transplantation four months prior was referred to our clinic with the chief complaint of gradually decreasing vision in both eyes for three months. During the funduscopic examination, multiple serous retinal detachments (SRD) were observed bilaterally, and he was diagnosed with multiple foci of central serous chorioretinopathy (CSCR). He was advised to discontinue the steroid dosage, which did not make significant improvement, and he was treated with intravitreal bevacizumab injection in the more severely affected eye. One month later, significant improvement was noticed in both eyes.
Conclusion: Serous retinal detachment is a rare complication following BMT. Significant bilateral improvement after single unilateral intravitreal bevacizumab injection shows not only the possible role of increased level of vascular endothelial growth factor (VEGF) in this case, but also the systemic diffusion of the drug and effect on the contralateral eye following unilateral injection. |
| first_indexed | 2024-04-12T15:36:16Z |
| format | Article |
| id | doaj.art-07fc4b97d3954d0da4524091b84d3586 |
| institution | Directory Open Access Journal |
| issn | 2008-322X |
| language | English |
| last_indexed | 2024-04-12T15:36:16Z |
| publishDate | 2019-01-01 |
| publisher | Knowledge E |
| record_format | Article |
| series | Journal of Ophthalmic & Vision Research |
| spelling | doaj.art-07fc4b97d3954d0da4524091b84d35862022-12-22T03:26:57ZengKnowledge EJournal of Ophthalmic & Vision Research2008-322X2019-01-0114221922210.4103/jovr.jovr_139_17Bilateral multiple serous retinal detachments following bone marrow transplantationPejvak AzadiAlireza LashayMohammad Riazi EsfahaniPurpose: To describe a case of bilateral multiple serous retinal detachments (SRD) following bone marrow transplantation (BMT), which showed bilateral response to a single unilateral intravitreal bevacizumab injection. Case Report: A 37-year-old man with acute myelogenous leukemia who had received bone marrow transplantation four months prior was referred to our clinic with the chief complaint of gradually decreasing vision in both eyes for three months. During the funduscopic examination, multiple serous retinal detachments (SRD) were observed bilaterally, and he was diagnosed with multiple foci of central serous chorioretinopathy (CSCR). He was advised to discontinue the steroid dosage, which did not make significant improvement, and he was treated with intravitreal bevacizumab injection in the more severely affected eye. One month later, significant improvement was noticed in both eyes. Conclusion: Serous retinal detachment is a rare complication following BMT. Significant bilateral improvement after single unilateral intravitreal bevacizumab injection shows not only the possible role of increased level of vascular endothelial growth factor (VEGF) in this case, but also the systemic diffusion of the drug and effect on the contralateral eye following unilateral injection.http://www.jovr.org/article.asp?issn=2008-322X;year=2019;volume=14;issue=2;spage=219;epage=222;aulast=AzadiAllogenic Bone Marrow Transplantation; Bevacizumab; Central Serous Chorioretinopathy; Serous Retinal Detachment; Vascular Endothelial Growth Factor |
| spellingShingle | Pejvak Azadi Alireza Lashay Mohammad Riazi Esfahani Bilateral multiple serous retinal detachments following bone marrow transplantation Journal of Ophthalmic & Vision Research Allogenic Bone Marrow Transplantation; Bevacizumab; Central Serous Chorioretinopathy; Serous Retinal Detachment; Vascular Endothelial Growth Factor |
| title | Bilateral multiple serous retinal detachments following bone marrow transplantation |
| title_full | Bilateral multiple serous retinal detachments following bone marrow transplantation |
| title_fullStr | Bilateral multiple serous retinal detachments following bone marrow transplantation |
| title_full_unstemmed | Bilateral multiple serous retinal detachments following bone marrow transplantation |
| title_short | Bilateral multiple serous retinal detachments following bone marrow transplantation |
| title_sort | bilateral multiple serous retinal detachments following bone marrow transplantation |
| topic | Allogenic Bone Marrow Transplantation; Bevacizumab; Central Serous Chorioretinopathy; Serous Retinal Detachment; Vascular Endothelial Growth Factor |
| url | http://www.jovr.org/article.asp?issn=2008-322X;year=2019;volume=14;issue=2;spage=219;epage=222;aulast=Azadi |
| work_keys_str_mv | AT pejvakazadi bilateralmultipleserousretinaldetachmentsfollowingbonemarrowtransplantation AT alirezalashay bilateralmultipleserousretinaldetachmentsfollowingbonemarrowtransplantation AT mohammadriaziesfahani bilateralmultipleserousretinaldetachmentsfollowingbonemarrowtransplantation |